New multiple-sclerosis drug approved by the FDA
Today the Food and Drug Administration approved Ampyra, a new drug owned by Biogen Idec. to fight multiple sclerosis. The new drug is an extended-release tablet aimed at helping to increase mobility in those battling against multiple sclerosis. The FDA said those who took the drug had better movemen